MyAverix Finance
SHG · Healthcare
Getein Biotech Inc (603387)
Medical Devices
Getein Biotech Inc (603387) is listed on SHG in the Healthcare sector. Industry: Medical Devices. As of 2026-03-29, reported market cap is $5.02B, P/E ratio is 24.15, net margin is 20.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603387
Getein Biotech Inc (603387) — FAQ
What is Getein Biotech Inc's market cap?
Getein Biotech Inc (603387) has a reported market cap of $5.02B (data as of 2026-03-29).
What is 603387's P/E ratio?
The price-to-earnings (P/E) ratio for Getein Biotech Inc (603387) is 24.15 (data as of 2026-03-29).
Does Getein Biotech Inc pay a dividend?
Dividend yield is not available in the current snapshot for Getein Biotech Inc (603387). Check the MyAverix Finance app for the latest dividend data.
What sector is Getein Biotech Inc in?
Getein Biotech Inc (603387) is classified in the Healthcare sector (Medical Devices industry).
What exchange is 603387 listed on?
603387 is listed on SHG.
What is Getein Biotech Inc's net margin?
Getein Biotech Inc (603387) reports a net margin of 20.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.